Online Database of Chemicals from Around the World

[3aa,4a(E),5b,6aa]-4-[4-(3-Chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one
[CAS# 67738-67-4]

List of Suppliers
Shenyang OllyChem Technology Co., Ltd. China Inquire  
+86 (24) 6225-9849
+86 13840042106
info@ollychem.com
oliverdu@ollychem.com
Chemical manufacturer since 2001
chemBlink standard supplier since 2007
Zhejiang Ausun Pharmaceutical Co., Ltd. China Inquire  
+86 (576) 8558-9335
+86 13957690608
sales@ausunpharm.com
Chemical manufacturer since 2011
chemBlink standard supplier since 2009
Alfa Chemistry USA Inquire  
+1 (201) 478-8534
inquiry@alfa-chemistry.com
Chemical distributor since 2012
chemBlink standard supplier since 2012
Complete supplier list of [3aa,4a(E),5b,6aa]-4-[4-(3-Chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one
Identification
Classification Flavors and spices >> Synthetic spice >> Lactone and oxygen-containing heterocyclic compound >> Furan and pyran
Name [3aa,4a(E),5b,6aa]-4-[4-(3-Chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one
Synonyms 4-[(E)-4-(3-chlorophenoxy)-3-oxobut-1-enyl]-5-hydroxy-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one
Molecular Structure CAS # 67738-67-4 (79356-61-9), [3aa,4a(E),5b,6aa]-4-[4-(3-Chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one, 4-[(E)-4-(3-chlorophenoxy)-3-oxobut-1-enyl]-5-hydroxy-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one
Molecular Formula C17H17ClO5
Molecular Weight 336.77
CAS Registry Number 67738-67-4 (79356-61-9)
SMILES C1C(C(C2C1OC(=O)C2)/C=C/C(=O)COC3=CC(=CC=C3)Cl)O
Properties
Density 1.4±0.1 g/cm3, Calc.*, 1.418
Index of Refraction 1.637, Calc.*
Boiling Point 537.8±50.0 ºC (760 mmHg), Calc.*
Flash Point 279.1±30.1 ºC, Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H302-H315-H319-H335    Details
Precautionary Statements P261-P280-P301+P312-P305+P351+P338    Details
SDS Available
up Discovory and Applicatios
The chemical substance [3aa,4a(E),5b,6aa]-4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one represents a significant advancement in synthetic organic chemistry, particularly in the development of novel therapeutic agents. This compound belongs to a class of molecules known for their intricate structural frameworks and potential bioactive properties.

The discovery of this specific compound is rooted in ongoing research aimed at synthesizing bioactive natural products and derivatives with improved pharmacological profiles. Its design draws inspiration from natural compounds, particularly those exhibiting anti-inflammatory and analgesic properties. The compound's unique structural features, including the hexahydro-2H-cyclopenta[b]furan framework, contribute to its biological activity, making it a point of interest in medicinal chemistry.

One of the primary applications of [3aa,4a(E),5b,6aa]-4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one lies in its potential as a pharmaceutical candidate. Its structural similarity to existing therapeutic agents allows researchers to explore its efficacy against various diseases, particularly in the realm of anti-inflammatory and analgesic therapies. The incorporation of a 3-chlorophenoxy group further enhances its activity by increasing lipophilicity and improving the compound's interaction with biological targets.

In addition to its pharmaceutical applications, this compound also serves as a valuable intermediate in synthetic organic chemistry. Its ability to undergo further modifications allows chemists to create a diverse array of derivatives, which can be screened for biological activity. The cyclopentafuran framework is particularly useful for the synthesis of compounds with diverse functionalities, enabling researchers to explore new avenues in drug discovery.

Furthermore, the study of this compound contributes to the broader understanding of structure-activity relationships (SAR) within the context of medicinal chemistry. By analyzing how variations in its structure affect biological activity, scientists can design more effective therapeutic agents with fewer side effects. This knowledge is crucial in the quest for developing targeted therapies that address specific medical conditions.

Research continues to focus on elucidating the precise mechanisms of action of [3aa,4a(E),5b,6aa]-4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one, as well as its potential in combination therapies. These investigations aim to establish the compound’s therapeutic window, efficacy, and safety profile in preclinical and clinical settings.

Overall, [3aa,4a(E),5b,6aa]-4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one exemplifies the innovative approaches in contemporary chemistry aimed at developing new therapeutic agents. Its structural complexity and potential bioactivity highlight its importance in the ongoing exploration of pharmaceuticals and the advancements in synthetic organic chemistry.
Market Analysis Reports
List of Reports Available for [3aa,4a(E),5b,6aa]-4-[4-(3-Chlorophenoxy)-3-oxo-1-butenyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one
Related Products
(5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3S)-4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid  (3aR,4R,5R,6aS)-4-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one  (3aR,4R,5R,6aS)-4-[(1E)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one  4-(2-Chlorophenoxy)-N-[3-[(methylamino)carbonyl]phenyl]-1-piperidinecarboxamide  2-(4-Chlorophenoxy)-3-methylbutanoic acid (3-phenoxyphenyl)methyl ester  2-(4-Chlorophenoxy)-2-methylpropionic acid  3-[(3-Chlorophenoxy)methyl]-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine  5-[(4-Chlorophenoxy)methyl]-1,3,4-thiadiazol-2-amine  1-(4-Chlorophenoxy)-4-nitrobenzene  3-(4-Chlorophenoxy)-4-nitrobenzoic acid methyl ester  (3aR,4R,5R,6aS)-4-[(1E)-4-(3-Chlorophenoxy)-3-oxo-1-buten-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one  4-(4-Chlorophenoxy)phenol  (2S)-2-[[4-(4-Chlorophenoxy)phenoxy]methyl]-1-pyrrolidinebutanoic acid  2-(4-Chlorophenoxy)phenylacetic acid  2-(5-Chloro-2-phenoxyphenyl)acetic acid  N-[2-(5-Chloro-2-phenoxyphenyl)acetyl]-N-methyl-glycine methyl ester  2-[4-(4-Chlorophenoxy)phenyl]-1H-benzimidazole-5-carboxamide  3-[2-(4-Chlorophenoxy)phenyl]-1,5-dihydro-4-hydroxy-1-methyl-2H-pyrrol-2-one  1-(5-Chloro-2-phenoxyphenyl)-ethanone  4-Chlorophenothiazine